Ranbaxy Stability Testing System Draws FDA GMP Warning Letter
This article was originally published in The Pink Sheet Daily
Executive Summary
An FDA analysis of isotretinoin samples following a February inspection finds “lower potencies in these batches” before their expiration dates.